Bin Wu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
- Gastric Cancer Management and Outcomes
- Prostate Cancer Treatment and Research
Papers in ⓘ
- Hepatology 21
- Hepatitis C virus research 12
- Co-authors
- Qiang Zhang (5 shared papers)Zhenlei Zha (13 shared papers)Hu Zhao (11 shared papers)Lizheng Shi (1 shared paper)Huafeng Chen (4 shared papers)Jun Yuan (11 shared papers)Jie Sun (1 shared paper)Ming Ye (5 shared papers)
- Journals
- Frontiers in Pharmacology (9 papers)PLoS ONE (6 papers)Frontiers in Oncology (4 papers)Clinical Therapeutics (3 papers)Value in Health (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Bin Wu
161 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 134
- Oncology 901
- Pulmonary and Respiratory Medicine 987
- Hepatology 235
- Cancer Research 234
- Internal Medicine 52
Countries citing papers authored by Bin Wu
This map shows the geographic impact of Bin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Wu more than expected).
Fields of papers citing papers by Bin Wu
This network shows the impact of papers produced by Bin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Wu. The network helps show where Bin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 131 | |
| 2 | 2009 | 129 | |
| 3 | 2018 | 96 | |
| 4 | 2012 | 86 | |
| 5 | 2013 | 76 | |
| 6 | 2022 | 65 | |
| 7 | 2019 | 64 | |
| 8 | 2018 | 62 | |
| 9 | 2017 | 58 | |
| 10 | 2018 | 58 | |
| 11 | 2010 | 52 | |
| 12 | 2018 | 51 | |
| 13 | 2018 | 51 | |
| 14 | 2018 | 51 | |
| 15 | 2011 | 49 | |
| 16 | 2018 | 48 | |
| 17 | 2020 | 46 | |
| 18 | 2016 | 45 | |
| 19 | 2023 | 41 | |
| 20 | 2021 | 41 |
About Bin Wu
Bin Wu is a scholar working on Hepatology, Internal Medicine, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 175 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Pancreatic and Hepatic Oncology Research (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (12 papers), Hepatitis C virus research (12 papers), Renal cell carcinoma treatment (11 papers) and Economic and Financial Impacts of Cancer (9 papers). The work is most often cited by research in Oncology (901 citations), Pulmonary and Respiratory Medicine (987 citations), Hepatology (235 citations), Cancer Research (234 citations) and Internal Medicine (52 citations). Bin Wu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qiang Zhang, Zhenlei Zha, Hu Zhao, Lizheng Shi, Huafeng Chen, Jun Yuan, Jie Sun, Ming Ye, Lijin Zhang and Shun Lü. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Frontiers in Oncology, Clinical Therapeutics and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.